Patients with chronic obstructive pulmonary disease (COPD) demonstrate a greater
osteoporosis prevalence than the general population. This osteoporosis risk may be …

Background Whether the use of inhaled corticosteroids (ICSs) in patients with COPD can
protect from osteoporosis remains undetermined. The aim of this study is to assess the …

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and
osteoporosis is the major comorbidity associated with poor prognosis in COPD. However …

Patients with COPD have high risk for osteoporosis and fractures. Hip and vertebral fractures
might impair mobility, and vertebral fractures further reduce lung function. This review …

ICS increases risk of bone demineralization and fracture in patients with COPD. It should be
generally avoided in patients with previous fractures or significant osteoporosis. If they are …

Introduction Chronic obstructive pulmonary disease (COPD) is characterised by persistent
airflow obstruction and respiratory symptoms. While short course systemic GCs are …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the
incidence of fracture or osteoporosis among patients with COPD. The aim of this meta …

Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …

Inhaled corticosteroids (ICS) at low to medium doses (< 1500 mcg beclomethasone
hydrofluoroalkane per day) for asthma and chronic obstructive pulmonary disease (COPD) …